Baeuerle Patrick 4
4 · Cullinan Oncology, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Baeuerle Patrick
See Remarks
Transactions
- Award
Common Stock
2022-02-11+37,500→ 37,500 total - Award
Stock Option (Right to Buy)
2022-02-11+75,000→ 75,000 totalExercise: $13.60Exp: 2032-02-10→ Common Stock (75,000 underlying)
Holdings
- 341,434(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]Shares held directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F3]The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.